Potential Use of Artificial Intelligence for Regulatory Intelligence: Biopharmaceutical Industry's Views.

Background: Pharmaceutical companies rely on regulatory intelligence (RI) to analyze information from internal and external sources. To facilitate RI activities, companies are seeking ways to harness technology to optimize their capabilities. Specifically, there is a growing interest for artificial intelligence (AI) to enhance RI activities.